Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients

BackgroundCirculating small RNAs (smRNAs) originate from diverse tissues and organs. Previous studies investigating smRNAs as potential biomarkers for Parkinson’s disease (PD) have yielded inconsistent results. We investigated whether smRNA profiles from neuronally-enriched serum exosomes and microv...

Full description

Bibliographic Details
Main Authors: Morris A. Aguilar, Shauna Ebanks, Havell Markus, Mechelle M. Lewis, Vishal Midya, Kent Vrana, Xuemei Huang, Molly A. Hall, Yuka Imamura Kawasawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1145923/full
_version_ 1827906787324461056
author Morris A. Aguilar
Morris A. Aguilar
Shauna Ebanks
Havell Markus
Mechelle M. Lewis
Mechelle M. Lewis
Vishal Midya
Kent Vrana
Xuemei Huang
Xuemei Huang
Molly A. Hall
Molly A. Hall
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
author_facet Morris A. Aguilar
Morris A. Aguilar
Shauna Ebanks
Havell Markus
Mechelle M. Lewis
Mechelle M. Lewis
Vishal Midya
Kent Vrana
Xuemei Huang
Xuemei Huang
Molly A. Hall
Molly A. Hall
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
author_sort Morris A. Aguilar
collection DOAJ
description BackgroundCirculating small RNAs (smRNAs) originate from diverse tissues and organs. Previous studies investigating smRNAs as potential biomarkers for Parkinson’s disease (PD) have yielded inconsistent results. We investigated whether smRNA profiles from neuronally-enriched serum exosomes and microvesicles are altered in PD patients and discriminate PD subjects from controls.MethodsDemographic, clinical, and serum samples were obtained from 60 PD subjects and 40 age- and sex-matched controls. Exosomes and microvesicles were extracted and isolated using a validated neuronal membrane marker (CD171). Sequencing and bioinformatics analyses were used to identify differentially expressed smRNAs in PD and control samples. SmRNAs also were tested for association with clinical metrics. Logistic regression and random forest classification models evaluated the discriminative value of the smRNAs.ResultsIn serum CD171 enriched exosomes and microvesicles, a panel of 29 smRNAs was expressed differentially between PD and controls (false discovery rate (FDR) < 0.05). Among the smRNAs, 23 were upregulated and 6 were downregulated in PD patients. Pathway analysis revealed links to cellular proliferation regulation and signaling. Least absolute shrinkage and selection operator adjusted for the multicollinearity of these smRNAs and association tests to clinical parameters via linear regression did not yield significant results. Univariate logistic regression models showed that four smRNAs achieved an AUC ≥ 0.74 to discriminate PD subjects from controls. The random forest model had an AUC of 0.942 for the 29 smRNA panel.ConclusionCD171-enriched exosomes and microvesicles contain the differential expression of smRNAs between PD and controls. Future studies are warranted to follow up on the findings and understand the scientific and clinical relevance.
first_indexed 2024-03-13T01:01:50Z
format Article
id doaj.art-313c638db17f417b971da0f5798c8ee5
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-03-13T01:01:50Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-313c638db17f417b971da0f5798c8ee52023-07-06T11:22:44ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2023-07-011710.3389/fnins.2023.11459231145923Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patientsMorris A. Aguilar0Morris A. Aguilar1Shauna Ebanks2Havell Markus3Mechelle M. Lewis4Mechelle M. Lewis5Vishal Midya6Kent Vrana7Xuemei Huang8Xuemei Huang9Molly A. Hall10Molly A. Hall11Yuka Imamura Kawasawa12Yuka Imamura Kawasawa13Yuka Imamura Kawasawa14Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, United StatesHuck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA, United StatesDepartment of Neurology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Neurology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Neurology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Pharmacology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Pharmacology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Neurology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Pharmacology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, United StatesHuck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA, United StatesDepartment of Pharmacology, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, United StatesInstitute for Personalized Medicine, College of Medicine, The Pennsylvania State University, Hershey, PA, United StatesBackgroundCirculating small RNAs (smRNAs) originate from diverse tissues and organs. Previous studies investigating smRNAs as potential biomarkers for Parkinson’s disease (PD) have yielded inconsistent results. We investigated whether smRNA profiles from neuronally-enriched serum exosomes and microvesicles are altered in PD patients and discriminate PD subjects from controls.MethodsDemographic, clinical, and serum samples were obtained from 60 PD subjects and 40 age- and sex-matched controls. Exosomes and microvesicles were extracted and isolated using a validated neuronal membrane marker (CD171). Sequencing and bioinformatics analyses were used to identify differentially expressed smRNAs in PD and control samples. SmRNAs also were tested for association with clinical metrics. Logistic regression and random forest classification models evaluated the discriminative value of the smRNAs.ResultsIn serum CD171 enriched exosomes and microvesicles, a panel of 29 smRNAs was expressed differentially between PD and controls (false discovery rate (FDR) < 0.05). Among the smRNAs, 23 were upregulated and 6 were downregulated in PD patients. Pathway analysis revealed links to cellular proliferation regulation and signaling. Least absolute shrinkage and selection operator adjusted for the multicollinearity of these smRNAs and association tests to clinical parameters via linear regression did not yield significant results. Univariate logistic regression models showed that four smRNAs achieved an AUC ≥ 0.74 to discriminate PD subjects from controls. The random forest model had an AUC of 0.942 for the 29 smRNA panel.ConclusionCD171-enriched exosomes and microvesicles contain the differential expression of smRNAs between PD and controls. Future studies are warranted to follow up on the findings and understand the scientific and clinical relevance.https://www.frontiersin.org/articles/10.3389/fnins.2023.1145923/fullParkinson’s diseaseexosomemicrovesiclesmall RNAbiomarkersregression
spellingShingle Morris A. Aguilar
Morris A. Aguilar
Shauna Ebanks
Havell Markus
Mechelle M. Lewis
Mechelle M. Lewis
Vishal Midya
Kent Vrana
Xuemei Huang
Xuemei Huang
Molly A. Hall
Molly A. Hall
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
Yuka Imamura Kawasawa
Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
Frontiers in Neuroscience
Parkinson’s disease
exosome
microvesicle
small RNA
biomarkers
regression
title Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
title_full Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
title_fullStr Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
title_full_unstemmed Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
title_short Neuronally enriched microvesicle RNAs are differentially expressed in the serums of Parkinson’s patients
title_sort neuronally enriched microvesicle rnas are differentially expressed in the serums of parkinson s patients
topic Parkinson’s disease
exosome
microvesicle
small RNA
biomarkers
regression
url https://www.frontiersin.org/articles/10.3389/fnins.2023.1145923/full
work_keys_str_mv AT morrisaaguilar neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT morrisaaguilar neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT shaunaebanks neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT havellmarkus neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT mechellemlewis neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT mechellemlewis neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT vishalmidya neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT kentvrana neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT xuemeihuang neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT xuemeihuang neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT mollyahall neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT mollyahall neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT yukaimamurakawasawa neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT yukaimamurakawasawa neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients
AT yukaimamurakawasawa neuronallyenrichedmicrovesiclernasaredifferentiallyexpressedintheserumsofparkinsonspatients